CVT-301

Acorda plans NDA for inhaled Parkinson’s drug after touting long-term safety data
Mass Device
Sat, 04/1/17 - 08:03 am
Acorda Therapeutics
Parkinson's Disease
CVT-301
Levodopa
Acorda stock surges 9% after positive late-stage clinical trial results for Parkinson's drug
Marketwatch
Thu, 02/9/17 - 10:49 am
Acorda Therapeutics
clinical trials
CVT-301
Parkinson's Disease
Acorda buys Civitas to gain access to Parkinson's drug
Yahoo/Reuters
Wed, 09/24/14 - 09:48 am
Acorda
Civitas
Parkinson's Disease
M&A
CVT-301
Citivas scoops up $38M B round for inhaled Parkinson's drug
Fierce Biotech
Wed, 09/11/13 - 11:30 am
Citivas
Parkinson's Disease
CVT-301
Levodopa